Success Rates with Nicotine Personal Vaporizers: a Prospective 6-month Pilot Study of Smokers Not Intending to Quit

Overview

Journal BMC Public Health

Publisher Biomed Central

Specialty Public Health

Date 2014 Nov 9

PMID 25380748

Citations 54

Authors

Riccardo Polosa

Pasquale Caponnetto

Marilena Maglia

Jaymin B Morjaria

Cristina Russo

Affiliations

Soon will be listed here.

Abstract

Background: Electronic cigarettes (e-Cigs) are an attractive long-term alternative nicotine source to conventional cigarettes. Although they may assist smokers to remain abstinent during their quit attempt, studies using first generation e-Cigs report low success rates. Second generation devices (personal vaporisers - PVs) may result in much higher quit rates, but their efficacy and safety in smoking cessation and/or reduction in clinical trials is unreported.

Method: We conducted a prospective proof-of-concept study monitoring modifications in smoking behaviour of 50 smokers (unwilling to quit) switched onto PVs. Participants attended five study visits: baseline, week-4, week-8, week-12 and week-24. Number of cigarettes/day (cigs/day) and exhaled carbon monoxide (eCO) levels were noted at each visit. Smoking reduction/abstinence rates, product usage, adverse events and subjective opinions of these products were also reviewed.

Results: Sustained 50% and 80% reduction in cigs/day at week-24 was reported in 15/50 (30%) and 7/50 (14%) participants with a reduction from 25cigs/day to 6cigs/day (p < 0.001) and 3cigs/day (p < 0.001), respectively. Smoking abstinence (self-reported abstinence from cigarette smoking verified by an eCO ≤10 ppm) at week-24 was observed in 18/50 (36%) participants, with 15/18 (83.3%) still using their PVs at the end of the study. Combined 50% reduction and smoking abstinence was shown in 33/50 (66%) participants. Throat/mouth irritation (35.6%), dry throat/mouth (28.9%), headache (26.7%) and dry cough (22.2%) were frequently reported early in the study, but waned substantially by week-24. Participants' perception and acceptance of the products was very good.

Conclusion: The use of second generation PVs substantially decreased cigarette consumption without causing significant adverse effects in smokers not intending to quit.

Trial Registration: (ClinicalTrials.gov Identifier: NCT02124200).

Citing Articles

Electronic cigarettes for smoking cessation.

Lindson N, Butler A, McRobbie H, Bullen C, Hajek P, Wu A Cochrane Database Syst Rev. 2025; 1:CD010216.

PMID: 39878158 PMC: 11776059. DOI: 10.1002/14651858.CD010216.pub9.

The potential of new nicotine and tobacco products as tools for people who smoke to quit combustible cigarettes - a systematic review of common practices and guidance towards a robust study protocol to measure cessation efficacy.

Pluym N, Burkhardt T, Scherer G, Scherer M Harm Reduct J. 2024; 21(1):130.

PMID: 38970058 PMC: 11225172. DOI: 10.1186/s12954-024-01047-1.

Electronic cigarettes for smoking cessation.

Lindson N, Butler A, McRobbie H, Bullen C, Hajek P, Begh R Cochrane Database Syst Rev. 2024; 1:CD010216.

PMID: 38189560 PMC: 10772980. DOI: 10.1002/14651858.CD010216.pub8.

E-cigarette use and respiratory symptoms in adults: A systematic review and meta-analysis.

Alqahtani M, Alenezi F, Almeshari M, Alanazi A, Ben Taleb Z, Kalan M Tob Induc Dis. 2023; 21:168.

PMID: 38098748 PMC: 10720266. DOI: 10.18332/tid/174660.

A multicenter prospective randomized controlled trial investigating the effects of combustion-free nicotine alternatives on cardiovascular risk factors and metabolic parameters in individuals with type 2 diabetes who smoke: the DiaSmokeFree study....

Krysinski A, Russo C, Campagna D, Di Pino A, John S, Belsey J Intern Emerg Med. 2023; 19(2):321-332.

PMID: 37999870 PMC: 10954907. DOI: 10.1007/s11739-023-03467-6.

References

Farsalinos K, Romagna G, Tsiapras D, Kyrzopoulos S, Spyrou A, Voudris V . Impact of flavour variability on electronic cigarette use experience: an internet survey. Int J Environ Res Public Health. 2013; 10(12):7272-82. PMC: 3881166. DOI: 10.3390/ijerph10127272. View

Wieslander G, Norback D, Lindgren T . Experimental exposure to propylene glycol mist in aviation emergency training: acute ocular and respiratory effects. Occup Environ Med. 2001; 58(10):649-55. PMC: 1740047. DOI: 10.1136/oem.58.10.649. View

Smith S, McCarthy D, Japuntich S, Christiansen B, Piper M, Jorenby D . Comparative effectiveness of 5 smoking cessation pharmacotherapies in primary care clinics. Arch Intern Med. 2009; 169(22):2148-55. PMC: 2891174. DOI: 10.1001/archinternmed.2009.426. View

Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M . Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control. 2010; 19(2):98-103. DOI: 10.1136/tc.2009.031567. View

Farsalinos K, Polosa R . Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf. 2014; 5(2):67-86. PMC: 4110871. DOI: 10.1177/2042098614524430. View

Alpert H, Connolly G, Biener L . A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation. Tob Control. 2012; 22(1):32-7. DOI: 10.1136/tobaccocontrol-2011-050129. View

Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J . Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013; 382(9905):1629-37. DOI: 10.1016/S0140-6736(13)61842-5. View

Casella G, Caponnetto P, Polosa R . Therapeutic advances in the treatment of nicotine addiction: present and future. Ther Adv Chronic Dis. 2012; 1(3):95-106. PMC: 3513862. DOI: 10.1177/2040622310374896. View

Etter J, Bullen C . Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction. 2011; 106(11):2017-28. DOI: 10.1111/j.1360-0443.2011.03505.x. View

10.

Zhu S, Lee M, Zhuang Y, Gamst A, Wolfson T . Interventions to increase smoking cessation at the population level: how much progress has been made in the last two decades?. Tob Control. 2012; 21(2):110-8. PMC: 3446870. DOI: 10.1136/tobaccocontrol-2011-050371. View

11.

Caponnetto P, Campagna D, Papale G, Russo C, Polosa R . The emerging phenomenon of electronic cigarettes. Expert Rev Respir Med. 2012; 6(1):63-74. DOI: 10.1586/ers.11.92. View

12.

Caponnetto P, Campagna D, Cibella F, Morjaria J, Caruso M, Russo C . EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013; 8(6):e66317. PMC: 3691171. DOI: 10.1371/journal.pone.0066317. View

13.

Fagerstrom K, Schneider N . Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1989; 12(2):159-82. DOI: 10.1007/BF00846549. View

14.

Stead L, Lancaster T . Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2012; 10:CD008286. DOI: 10.1002/14651858.CD008286.pub2. View

15.

Varughese S, Teschke K, Brauer M, Chow Y, van Netten C, Kennedy S . Effects of theatrical smokes and fogs on respiratory health in the entertainment industry. Am J Ind Med. 2005; 47(5):411-8. DOI: 10.1002/ajim.20151. View

16.

Polosa R, Caponnetto P, Morjaria J, Papale G, Campagna D, Russo C . Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health. 2011; 11:786. PMC: 3203079. DOI: 10.1186/1471-2458-11-786. View

17.

Dawkins L, Turner J, Roberts A, Soar K . 'Vaping' profiles and preferences: an online survey of electronic cigarette users. Addiction. 2013; 108(6):1115-25. DOI: 10.1111/add.12150. View

18.

Dawkins L, Corcoran O . Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology (Berl). 2013; 231(2):401-7. DOI: 10.1007/s00213-013-3249-8. View

19.

Fagerstrom K, Hughes J, Rasmussen T, Callas P . Randomised trial investigating effect of a novel nicotine delivery device (Eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit. Tob Control. 2000; 9(3):327-33. PMC: 1748373. DOI: 10.1136/tc.9.3.327. View

20.

Polosa R, Benowitz N . Treatment of nicotine addiction: present therapeutic options and pipeline developments. Trends Pharmacol Sci. 2011; 32(5):281-9. PMC: 5564372. DOI: 10.1016/j.tips.2010.12.008. View